EW:NYSE
Edwards Lifesciences Corp
$84.92
arrow_downward
-0.31%(-0.26) 1D
Oct 2, 9:48:00 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$85.52
High
$85.88
Low
$84.66
Mkt. cap
48.95B
Avg. vol.
3.23M
Volume
101.36K
P/E ratio
49.13
52-wk high
$96.29
52-wk low
$72.30
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
Open
$85.52
High
$85.88
Low
$84.66
Mkt. cap
48.95B
Avg. vol.
3.23M
Volume
101.36K
P/E ratio
49.13
52-wk high
$96.29
52-wk low
$72.30
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
News stories
From web sources and news partners
Benzinga
·
5 hours ago
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
News Corp
·
17 hours ago
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day
Business Wire
·
17 hours ago
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
AD HOC NEWS
·
22 hours ago
Wall Street Zen downgrades Edwards Lifesciences stock to Hold
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com